Pfizer Covid vaccine for young children may not be renewed by FDA
The FDA may not renew the approval of Pfizer's COVID-19 vaccine for young children this fall, according to an email obtained by The Guardian. This decision could lead to Moderna potentially filling the gap in vaccine supply for children under five. The email indicates that Pfizer was informed that the FDA approval may not be granted, potentially leaving Moderna as the sole provider of a COVID-19 vaccine for this age group. The withdrawal of Pfizer's vaccine would mean that the only remaining COVID-19 vaccine option for all children under five would be removed from the market. The article does not provide further details on the reasons behind the FDA's potential decision or the potential impact on the availability of COVID-19 vaccines for young children in the United States.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
